HK1204277A1 - Compositions and methods for treating demodex infestations - Google Patents

Compositions and methods for treating demodex infestations Download PDF

Info

Publication number
HK1204277A1
HK1204277A1 HK15104850.4A HK15104850A HK1204277A1 HK 1204277 A1 HK1204277 A1 HK 1204277A1 HK 15104850 A HK15104850 A HK 15104850A HK 1204277 A1 HK1204277 A1 HK 1204277A1
Authority
HK
Hong Kong
Prior art keywords
composition
demodex
tea tree
tree oil
treating
Prior art date
Application number
HK15104850.4A
Other languages
English (en)
Chinese (zh)
Inventor
高瑩瑩
高莹莹
謝弗‧
谢弗‧C‧G‧曾
‧曾
Original Assignee
蒂休特赫公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 蒂休特赫公司 filed Critical 蒂休特赫公司
Publication of HK1204277A1 publication Critical patent/HK1204277A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HK15104850.4A 2007-08-29 2015-05-21 Compositions and methods for treating demodex infestations HK1204277A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/846,961 US8128968B2 (en) 2007-08-29 2007-08-29 Compositions and methods for treating Demodex infestations
US11/846,961 2007-08-29

Publications (1)

Publication Number Publication Date
HK1204277A1 true HK1204277A1 (en) 2015-11-13

Family

ID=40407911

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15104850.4A HK1204277A1 (en) 2007-08-29 2015-05-21 Compositions and methods for treating demodex infestations

Country Status (8)

Country Link
US (3) US8128968B2 (https=)
EP (1) EP2192913A4 (https=)
JP (1) JP2010538011A (https=)
KR (1) KR101176380B1 (https=)
CN (2) CN104189091A (https=)
CA (1) CA2694767C (https=)
HK (1) HK1204277A1 (https=)
WO (1) WO2009032773A2 (https=)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090214676A1 (en) 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
US8128968B2 (en) * 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations
US8895080B2 (en) 2008-06-20 2014-11-25 Ocusoft, Inc. Compositions and kits for ocular treatment
US20090317503A1 (en) * 2008-06-20 2009-12-24 Ocusoft, Inc. Eyelid Preparation and Method of Use
KR101022550B1 (ko) 2009-06-02 2011-03-16 고인순 모낭충 제거 효과를 갖는 크렌징 조성물
KR101792778B1 (ko) 2010-10-26 2017-11-01 삼성전자주식회사 비휘발성 메모리 장치 및 그 형성 방법
WO2012092320A2 (en) * 2010-12-29 2012-07-05 Nichamin Louis D Eye treatment
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
IL217807A (en) 2012-01-29 2017-01-31 Tel-Ari Ruben Local medical preparations based on tto
CN103055158A (zh) * 2012-12-27 2013-04-24 王荣华 一种治疗鳞屑性睑缘炎的中药组合物
WO2019126541A1 (en) * 2017-12-20 2019-06-27 Attillaps Holdings Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
US11446241B2 (en) * 2013-07-29 2022-09-20 Attillaps Holdings Inc. Treatment of ophthalmological conditions with acetylcholinesterase inhibitors
DE102013223795A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223789A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223790A1 (de) 2013-11-21 2015-05-21 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223793A1 (de) 2013-11-21 2014-04-10 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
DE102013223792A1 (de) 2013-11-21 2015-05-21 Henkel Ag & Co. Kgaa Verwendung kosmetischer Zusammensetzungen für die Inaktivierung und/oder Eliminierung von Hautmilben
US10172902B2 (en) 2014-05-28 2019-01-08 Lunovus Llc Ocular eyelid scrub composition for the treatment of demodex blepharitis
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
EP4088724B1 (en) * 2014-06-19 2024-10-23 Attillaps Holdings Acetylcholinesterase inhibitors for the oral treatment of dermatological conditions
RU2558074C1 (ru) * 2014-07-08 2015-07-27 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт ветеринарной энтомологии и арахнологии" (ФГБНУ ВНИИВЭА) Способ лечения демодекоза крупного рогатого скота
TW201625229A (zh) * 2014-07-14 2016-07-16 組織科技股份有限公司 用於治療玫瑰斑之組成物及方法
WO2016022066A1 (en) 2014-08-04 2016-02-11 Jerry Tan Eye Surgery Pte Ltd Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
US9463201B2 (en) 2014-10-19 2016-10-11 M.G. Therapeutics Ltd Compositions and methods for the treatment of meibomian gland dysfunction
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
US10688122B2 (en) 2015-09-28 2020-06-23 Azura Ophthalmics Ltd. Thiol and disulfide-containing agents for increasing meibomian gland lipid secretion
US11040062B2 (en) 2016-04-14 2021-06-22 Azura Ophthalmics Ltd. Selenium disulfide compositions for use in treating meibomian gland dysfunction
IT201600096125A1 (it) 2016-09-26 2018-03-26 Ntc Srl Complesso e composizioni per il trattamento di affezioni oculari e cutanee
RU2652073C1 (ru) * 2017-04-28 2018-04-24 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ) Способ лечения блефарита
PL3415142T3 (pl) 2017-06-12 2021-07-26 Novax Pharma S.A.M. Kompozycja do leczenia zapalenia brzegów powiek zawierająca terpinen-4-ol
WO2019057899A1 (en) 2017-09-22 2019-03-28 Lipid Systems Sp. Z.O.O. AQUEOUS COMPOSITION COMPRISING AT LEAST ONE PHOSHOLIPID AND AT LEAST ONE TERPENE WITH ACIDICITY ACTIVITY AGAINST DEMODEX
AU2018385766B2 (en) 2017-12-15 2022-12-01 Tarsus Pharmaceuticals, Inc. Isoxazoline parasiticide formulations and methods for treating blepharitis
JP7569781B2 (ja) 2018-07-27 2024-10-18 アペルタ バイオサイエンシズ，エルエルシー デモデックスにより誘発される眼の異常および顔面の異常を治療するためのスピノシン配合
CN109077947A (zh) * 2018-08-30 2018-12-25 湖北舒邦药业有限公司 一种医用眼科冷敷敷料及其制备方法
US20230165798A1 (en) * 2018-10-12 2023-06-01 Hovione Scientia Macrocyclic lactone formulations, methods of their preparation and use of the formulations in treating pathologies secondary to ophthalmic parasites
US12502377B2 (en) 2019-04-04 2025-12-23 Tarsus Pharmaceuticals, Inc. Method of eradicating ticks that attach to humans using lotilaner formulations
US12161752B2 (en) 2019-08-20 2024-12-10 Vishwanath Padmanabhan Compositions and methods for the treatment of anterior blepharitis and posterior blepharitis
WO2021090058A2 (en) * 2019-11-04 2021-05-14 Azura Ophthalmics Ltd. Metered dose for demodex and disorders related thereto
EP4087655A4 (en) 2020-01-10 2024-02-21 Azura Ophthalmics Ltd INSTRUCTIONS FOR COMPOSITION AND SENSITIVITY
CN111297948B (zh) * 2020-02-13 2021-12-14 周立光 一种治疗蠕形螨睑缘炎的眼贴和制备方法
CN111265666A (zh) * 2020-03-20 2020-06-12 山东省眼科医院 一种治疗螨虫性睑缘炎的茶树油制剂及其制备方法
US20220323472A1 (en) * 2021-03-30 2022-10-13 Frank Anthony SPALLITTA Anti-parasitic compounds for the treatment and prevention of viral diseases
WO2023211823A1 (en) 2022-04-25 2023-11-02 Biotissue Holdings Inc. Compositions and methods relating to pooled fetal support tissue
CN116602879B (zh) * 2023-04-25 2026-02-10 马应龙大健康有限公司 一种除螨组合物、含有该组合物的除螨添加剂及其制备方法及应用

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7607496L (sv) * 1976-07-01 1978-01-02 Astra Laekemedel Ab Sett for bekempning av virusinfektioner
AU559001B2 (en) * 1980-09-05 1987-02-19 Sedgewick, S.E. Skin cream containing tea tree oil
US4745100A (en) * 1985-05-14 1988-05-17 Eye Research Institute Of Retina Foundation Stimulation of tear secretion
US5208257A (en) * 1986-04-21 1993-05-04 Kabara Jon J Topical antimicrobial pharmaceutical compositions and methods
CA1296329C (en) * 1986-06-06 1992-02-25 Derek R. Sutherland Macrolide compounds
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
JPH04198131A (ja) * 1990-11-28 1992-07-17 Takeda Chem Ind Ltd 創傷治癒促進剤およびそれを含有する外用組成物
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
US5444043A (en) * 1994-02-18 1995-08-22 The Regents Of The University Of California Cyclic heptapeptide anti-inflammatory agent
US5888984A (en) * 1994-05-12 1999-03-30 Dermal Research Laboratories, Inc. Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
DE19511429A1 (de) * 1995-03-29 1996-10-02 Gerhard Linnhoff Pflegemittel für Haustiere und seine Anwendungen
US6022529A (en) * 1997-08-06 2000-02-08 California Institute Of Technology Photoresponsive sunscreen compositions
US6197305B1 (en) * 1998-01-05 2001-03-06 Farmo-Nat Ltd. Anti-fungal compositions with prolonged activity
DE19824681A1 (de) 1998-06-03 1999-12-09 Grewe Helmut F Milben tötendes Reinigungsmittel für Körper und Haare
GB2370989A (en) * 2001-01-16 2002-07-17 Btg Int Ltd Piperine analogues for the treatment of skin conditions
US20010051184A1 (en) * 1999-05-20 2001-12-13 Madalene C.Y. Heng Method for using soluble curcumin to inhibit phosphorylase kinase in inflammatory diseases
US20040235742A1 (en) 1999-08-10 2004-11-25 Santen Pharmaceutical Co., Ltd. Water channel opener compositions and medicinal compositions for ophthalmic use
WO2001012225A1 (en) 1999-08-10 2001-02-22 Santen Pharmaceutical Co., Ltd. Water channel opener compositions and medicinal compositions for ophthalmic use
US6414036B1 (en) * 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
US6541042B1 (en) * 1999-10-27 2003-04-01 Bogar Ag Therapeutically effective combination
GB2362574B (en) * 2001-01-12 2002-04-24 Angus Erskine Stuart A formulation for the destruction of the eggs of chicken mites (Dermanyssus Gallinae)
US7121666B2 (en) 2001-04-25 2006-10-17 Tseng Scheffer C G Apparatus and method for the kinetic analysis of tear stability
CA2446372A1 (en) 2001-05-09 2002-11-14 Medicis Pharmaceutical Corporation Ectoparasiticidal compositions and methods of their use
IL158509A (en) * 2003-10-20 2010-11-30 Biomor Israel Ltd Non-phytotoxic biocide composition containing tea tree oil and method for production thereof
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US20040197364A1 (en) * 2003-01-24 2004-10-07 Brown Paul R. Topical insect repellent
EP1624881A4 (en) 2003-04-24 2010-01-06 Tyratech Inc COMPOSITIONS AND METHODS FOR REGULATION OF INSECTS
US20050220742A1 (en) * 2004-03-31 2005-10-06 Breen Ed V Compositions and methods for maintaining eyelid hygiene
US20060068044A1 (en) * 2004-09-30 2006-03-30 Max Reynolds Antimicrobial compositions and applications therefore
US20060147408A1 (en) * 2005-01-06 2006-07-06 Vision Endurance Resource, Inc. Skin cleansing and sloughing solution
US20060188492A1 (en) 2005-01-13 2006-08-24 Chronorx Llc, An Alaska Limited Liability Company Topical management of ocular and periocular conditions
ZA200706401B (en) * 2005-01-20 2008-11-26 Kayban Pty Ltd Anti-Microbial Agent
US20090214676A1 (en) 2005-04-30 2009-08-27 Tissuetech, Inc. Method for treating ocular demodex
US7875620B2 (en) * 2005-06-30 2011-01-25 Piper Medical, Inc. Methods of treating microbial infections
USRE43583E1 (en) 2006-06-16 2012-08-14 Rohto Pharmaceutical Co., Ltd. Ophthalmic composition for soft contact lens comprising terpenoid
US8202853B2 (en) * 2006-11-03 2012-06-19 Ocusoft, Inc. Convenience kit for eyelid treatment
US8128968B2 (en) 2007-08-29 2012-03-06 Tissuetech, Inc. Compositions and methods for treating Demodex infestations

Also Published As

Publication number Publication date
US8865233B2 (en) 2014-10-21
CN104189091A (zh) 2014-12-10
WO2009032773A3 (en) 2009-04-30
EP2192913A4 (en) 2011-03-02
WO2009032773A2 (en) 2009-03-12
CN101795700A (zh) 2010-08-04
US8128968B2 (en) 2012-03-06
EP2192913A2 (en) 2010-06-09
CA2694767A1 (en) 2009-03-12
US8455015B2 (en) 2013-06-04
KR20100052541A (ko) 2010-05-19
KR101176380B1 (ko) 2012-08-24
US20100273870A1 (en) 2010-10-28
JP2010538011A (ja) 2010-12-09
CA2694767C (en) 2017-11-07
US20090061025A1 (en) 2009-03-05
US20130224272A1 (en) 2013-08-29

Similar Documents

Publication Publication Date Title
HK1204277A1 (en) Compositions and methods for treating demodex infestations
US12257263B2 (en) Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
US8440240B2 (en) Method for treating ocular demodex
Yeu et al. Lotilaner ophthalmic solution, 0.25%, for the treatment of Demodex blepharitis: results of a prospective, randomized, vehicle-controlled, double-masked, pivotal trial (Saturn-1)
Kheirkhah et al. Corneal manifestations of ocular demodex infestation
Hebert et al. Once‐daily mometasone furoate aqueous nasal spray (Nasonex®) in seasonal allergic rhinitis: an active‐and placebo‐controlled study
Gao et al. Treatment of ocular itching associated with ocular demodicosis by 5% tea tree oil ointment
Gonzalez-Salinas et al. Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: a randomized, controlled, double-masked clinical trial
Ergun et al. Comparison of efficacy and safety of two tea tree oil-based formulations in patients with chronic blepharitis: a double-blinded randomized clinical trial
JP7846616B2 (ja) 眼または眼の周囲における障害のための計量投与量
Fujishima et al. Safety and efficacy of a novel 0.5% epinastine topical eyelid cream in allergic conjunctivitis: a phase 3 trial
US20220323487A1 (en) Metered dose for demodex and disorders related thereto
WO2019113519A1 (en) Topical ointment formulations of pde-4 inhibitor and their use in treating skin conditions
US20250041212A1 (en) Compositions and methods for the treatment of anterior blepharitis and posterior blepharitis
US6395721B1 (en) Low potency unpreserved sterile topical corticosteroid compositions for dermatitis
EP3199163A1 (en) Composition of doxycycline in liposomes for the prevention, improvement and/or treatment of ocular pathologies
Ilomuanya et al. Safety evaluation of different variants of a topically applied toilet bar soap range using skin irritancy testing methods in the Nigerian population
Pawełczyk Treatment options of human demodicosis
JP2019516796A (ja) 皮膚疾患を治療／予防するためのカルボン酸
Roller et al. Acne: Pimples, zits and spots
O’Haver et al. Dermatological Problems
US20220062308A1 (en) Methods and compositions for treating rosacea
JP2024128926A (ja) 顔の皮膚状態の改善剤
HK40090169A (zh) 用於治疗干眼病的调配物
Buensalido et al. The efficacy and safety of 1.5% Carica papaya latex cream compared to 2% ketoconazole cream and vehicle in the treatment of tinea corporis: A randomized, double blind, controlled trial